11/4
12:09 pm
fate
Fate Therapeutics (NASDAQ:FATE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Medium
Report
Fate Therapeutics (NASDAQ:FATE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
10/31
07:19 am
fate
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
Medium
Report
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
10/31
06:12 am
fate
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
10/31
06:12 am
fate
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
10/27
08:43 am
fate
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
High
Report
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
10/27
08:43 am
fate
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
High
Report
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
10/27
08:37 am
fate
Rating for FATE
High
Report
Rating for FATE
10/27
08:37 am
fate
Rating for FATE
High
Report
Rating for FATE
10/27
08:06 am
fate
Fate Therapeutics (NASDAQ:FATE) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
High
Report
Fate Therapeutics (NASDAQ:FATE) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
10/27
07:03 am
fate
Fate Therapeutics upgraded to Outperform from Neutral at Wedbush
High
Report
Fate Therapeutics upgraded to Outperform from Neutral at Wedbush
10/27
07:03 am
fate
Fate Therapeutics upgraded to Outperform from Neutral at Wedbush
High
Report
Fate Therapeutics upgraded to Outperform from Neutral at Wedbush
10/27
05:38 am
fate
Rating for FATE
High
Report
Rating for FATE
10/27
05:38 am
fate
Rating for FATE
High
Report
Rating for FATE